Lupin strengthens diabetes portfolio with acquisition of Gibtulio, Gibtulio Met, and Ajaduo trademarks from Boehringer ...
An estimated 80 million people above the age of 18 years have diabetes in India, in addition to 25 million 2 that are pre-diabetic.
Lupin Limited today announced the acquisition of anti-diabetes trademarks GIBTULIO®, GIBTULIO MET® and AJADUO® from ...
Drug firm Lupin Ltd on Friday (December 13) announced the acquisition of trademarks for three anti-diabetes brands — Gibtulio ... "The increasing prevalence of diabetes and related lifestyle diseases ...
Vertex Pharmaceuticals said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed ...
4 天
The Brighterside of News on MSNNew diabetes drug HPH-15 proves to be significantly better than existing wonder drugsDiabetes, a chronic condition impacting millions globally, often brings along complications like insulin resistance and fatty ...
6, 2024 — Scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment ...
Lupin Ltd. on Friday said it has acquired trademarks of three anti-diabetes medications from German pharmaceutical company Boehringer Ingelheim. According to the ...
In patients with Type 2 diabetes mellitus (T2DM), adequate glycemic control is a critical factor in reducing long-term micro- and macro-vascular complications. Traditionally, the approach is to ...
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果